期刊文献+

慢性阻塞性肺疾病患者呼出气冷凝液中IL-8与8-异向前列腺素的变化及临床意义 被引量:2

Clinical Significance of Changes in Interleukin-8 and 8-Isoprostane Levels in Exhaled Breath Condensate in Patients with Chronic Obstructive Pulmonary Disease
下载PDF
导出
摘要 目的观察慢性阻塞性肺疾病(COPD)患者呼出气冷凝液(EBC)中IL-8与8-异向前列腺素水平的变化。方法对已确诊为COPD的30例患者(急性加重期和稳定期各15例)及15例健康志愿者(对照组),采用呼出气冷凝液(EBC)收集器收集患者和健康志愿者的EBC,EBC中IL-8的检测采用酶联免疫吸附法(ELISA)、8-异向前腺素的检测采用酶免疫法(EIA),同时测定肺功能。结果 COPD急性加重期患者EBC中IL-8的水平为(861.146 3±679.428 2)ng·L-1,明显高于COPD稳定期患者的水平(416.213 2±383.965 1)ng·L-1(P<0.05);COPD急性加重期患者EBC中8-异向前列腺素的水平为(6.110±2.325)ng·L-1,明显高于COPD稳定期患者的水平(2.980±1.893)ng·L-1(P<0.05)。COPD患者EBC中IL-8与FEV1%、FEV1/FVC呈正相关(r=0.396、0.512,均P<0.01);8-异向前列腺素与FEV1%、FEV1/FVC呈负相关(r=-0.39、-0.76,均P>0.05)。结论 EBC的收集过程无创、安全、简便、可行。COPD患者EBC中的IL-8和8-异向前列腺素可作为评价COPD气道炎症反应、氧化应激状态和病情严重程度的较好指标。 Objective To observe the changes in the levels of intedeukin-8 (IL-8) and 8- isoprostane in exhaled breath condensate (EBC) in patients with chronic obstructive pulmonary disease (COPD). Methods The EBC was collected using EcoScreen in 15 patients with acute exacerbation of COPD, 15 patients with stable phase of COPD and 15 healthy subjects. The levels of IL-8 and 8- isoprostane in EBC were detected by ELISA and EIA, respectively. In addition, lung function was determined. Results Compared with patients with stable phase of COPD, both IL-8 and 8-isoprostane levels significantly increased in patients with acute exacerbation of COPD [(861.146 3-+679.428 2) ng.L-1 vs (416.213 2+383.965 1) ng.L-1 and (6.110_+2.325) ng'L-lvs (2.980~1.893) ng.L-~, respectively; P〈 0.05). The levels of IL-8 in EBC were positively correlated with FEVI% and FEV1/FVC in COPD patients (r--0.396 and 0.512, respectively, P〈0.01 ). However, the levels of 8-isoprostane in EBC were negatively correlated with FEV1% and FEV1/FVC in COPD patients (r=-0.39 and -0.76, respectively, P〉0.05). Conclusion EcoScreen is non-invasive, safe, simple and feasible for the collection of EBC. The levels of IL-8 and 8-isoprostane in EBC can be used as the indicators for assessing airway inflammation, oxidative stress and disease severity in patients with COPD.
出处 《实用临床医学(江西)》 CAS 2013年第7期3-5,14,共4页 Practical Clinical Medicine
基金 江西省卫生厅科技计划(20091263)
关键词 慢性阻塞性肺疾病 呼出气冷凝液 白介素-8 8-异向前腺素 chronic obstructive pulmonary disease exhaled breath condensate interleukin-8 8-isoprostane
  • 相关文献

参考文献9

二级参考文献67

  • 1有创-无创序贯机械通气多中心研究协作组.以肺部感染控制窗为切换点行有创与无创序贯机械通气治疗慢性阻塞性肺疾病所致严重呼吸衰竭的随机对照研究[J].中华结核和呼吸杂志,2006,29(1):14-18. 被引量:279
  • 2慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8240
  • 3Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med, 2001,163:1693-1722.
  • 4K ietzmann D,Kahl R, MOiler M, et al. Hydrogen peroxide in expired breath condensate of patients with acute respiratory failure and with ARDS. Intensive Care Med, 1993,19:78-81.
  • 5Baldwin SR,Simon RH, Grum CM, et al. Oxidant activity in expired breath of patients with adult respiratory distress syndrome. Lancet, 1986,1 : 11-14.
  • 6Wilson WC, Swetland JF, Benumof JL, et al. General anesthesia and exhaled breath hydrogen peroxide. Anesthesiology, 1992,76 : 703-710.
  • 7Horvath I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J, 2005,26 : 523-548.
  • 8Carpenter CT, Price PV, Christman BW. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS. Chest, 1998,114 : 1653-1659.
  • 9Gessner C, Dihazi H, Brettschneider S, et al. Presence of eytokeratins in exhaled breath condensate of mechanical ventilated patients. Respir Med, 2008,102 : 299-306.
  • 10Gessner C, Scheibe R, Wotzel M, et al. Exhaled breath condensate cytokine patterns in chronic obstructive pulmonary disease. Respir Meal,2005,99: 1229-1240.

共引文献8244

同被引文献28

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部